These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 24111789)
1. TTF-1 expression in breast carcinoma: an unusual but real phenomenon. Ni YB; Tsang JY; Shao MM; Chan SK; Tong J; To KF; Tse GM Histopathology; 2014 Mar; 64(4):504-11. PubMed ID: 24111789 [TBL] [Abstract][Full Text] [Related]
2. Significant expression of thyroid transcription factor-1 in pulmonary squamous cell carcinoma detected by SPT24 monoclonal antibody and CSA-II system. Kashima K; Hashimoto H; Nishida H; Arakane M; Yada N; Daa T; Yokoyama S Appl Immunohistochem Mol Morphol; 2014; 22(2):119-24. PubMed ID: 23531851 [TBL] [Abstract][Full Text] [Related]
3. Thyroid transcription factor-1 expression in colorectal adenocarcinomas. Dettmer M; Kim TE; Jung CK; Jung ES; Lee KY; Kang CS Pathol Res Pract; 2011 Nov; 207(11):686-90. PubMed ID: 22019009 [TBL] [Abstract][Full Text] [Related]
4. Unusual expression of thyroid transcription factor 1 and napsin A in metastatic adenoid cystic carcinoma of extrapulmonary origin in the lung. An J; Park S; Sung SH; Cho MS; Kim SC Am J Clin Pathol; 2014 May; 141(5):712-7. PubMed ID: 24713744 [TBL] [Abstract][Full Text] [Related]
5. Value of thyroid transcription factor-1 and surfactant apoprotein A in the differential diagnosis of pulmonary carcinomas: a study of 109 cases. Zamecnik J; Kodet R Virchows Arch; 2002 Apr; 440(4):353-61. PubMed ID: 11956814 [TBL] [Abstract][Full Text] [Related]
6. TTF-1 expression in ovarian and uterine epithelial neoplasia and its potential significance, an immunohistochemical assessment with multiple monoclonal antibodies and different secondary detection systems. Zhang PJ; Gao HG; Pasha TL; Litzky L; Livolsi VA Int J Gynecol Pathol; 2009 Jan; 28(1):10-8. PubMed ID: 19047914 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic Utility of Thyroid Transcription Factor-1 in Ovarian Carcinoma and Its Relationship With Clinicopathologic Prognostic Parameters. Hakim SA; Youssef NS Appl Immunohistochem Mol Morphol; 2017 Apr; 25(4):237-243. PubMed ID: 26657873 [TBL] [Abstract][Full Text] [Related]
8. Various Antibody Clones of Napsin A, Thyroid Transcription Factor 1, and p40 and Comparisons With Cytokeratin 5 and p63 in Histopathologic Diagnostics of Non-Small Cell Lung Carcinoma. Tran L; Mattsson JS; Nodin B; Jönsson P; Planck M; Jirström K; Botling J; Micke P; Brunnström H Appl Immunohistochem Mol Morphol; 2016 Oct; 24(9):648-659. PubMed ID: 26447895 [TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody to thyroid transcription factor-1: production, characterization, and usefulness in tumor diagnosis. Holzinger A; Dingle S; Bejarano PA; Miller MA; Weaver TE; DiLauro R; Whitsett JA Hybridoma; 1996 Feb; 15(1):49-53. PubMed ID: 9064286 [TBL] [Abstract][Full Text] [Related]
10. Thyroid transcription factor-1 expression in breast carcinomas. Robens J; Goldstein L; Gown AM; Schnitt SJ Am J Surg Pathol; 2010 Dec; 34(12):1881-5. PubMed ID: 21107096 [TBL] [Abstract][Full Text] [Related]
11. Surfactant proteins and thyroid transcription factor-1 in pulmonary and breast carcinomas. Bejarano PA; Baughman RP; Biddinger PW; Miller MA; Fenoglio-Preiser C; al-Kafaji B; Di Lauro R; Whitsett JA Mod Pathol; 1996 Apr; 9(4):445-52. PubMed ID: 8729987 [TBL] [Abstract][Full Text] [Related]
12. Value of thyroid transcription factor-1 immunostaining in tumor diagnosis: a review and update. Ordóñez NG Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):429-44. PubMed ID: 22531688 [TBL] [Abstract][Full Text] [Related]
13. Patterns of Immunoreactivity with TTF-1 Antibodies 8G7G3/1 and SPT24 Suggest Distinct Immunoprofiles Between Most Pulmonary and Nonpulmonary Small Cell Carcinomas. Briski LM; Aron M; Epstein JI; Russell DH; Assarzadegan N; Delma KS; O'Dell H; Rodriguez E; Montgomery EA; Kryvenko ON Int J Surg Pathol; 2024 Apr; 32(2):230-238. PubMed ID: 37170625 [No Abstract] [Full Text] [Related]
14. Comparison of thyroid transcription factor-1 expression by 2 monoclonal antibodies in pulmonary and nonpulmonary primary tumors. Matoso A; Singh K; Jacob R; Greaves WO; Tavares R; Noble L; Resnick MB; Delellis RA; Wang LJ Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):142-9. PubMed ID: 19887917 [TBL] [Abstract][Full Text] [Related]
15. The Incidence of Labelling of Non-Lung Adenocarcinomas With Antibodies Against TTF-1 and Diagnostic Implications. Prabhakaran S; Woo WLW; Xing G; Moffat D; Hussey M; Henderson DW; Klebe S Appl Immunohistochem Mol Morphol; 2020 Jul; 28(6):471-476. PubMed ID: 31135446 [TBL] [Abstract][Full Text] [Related]
17. Comparison of Three Different TTF-1 Clones in Resected Primary Lung Cancer and Epithelial Pulmonary Metastases. Vidarsdottir H; Tran L; Nodin B; Jirström K; Planck M; Mattsson JSM; Botling J; Micke P; Jönsson P; Brunnström H Am J Clin Pathol; 2018 Oct; 150(6):533-544. PubMed ID: 30169783 [TBL] [Abstract][Full Text] [Related]
18. Cytoplasmic immunoreactivity of thyroid transcription factor-1 (clone 8G7G3/1) in hepatocytes: true positivity or cross-reaction? Gu K; Shah V; Ma C; Zhang L; Yang M Am J Clin Pathol; 2007 Sep; 128(3):382-8. PubMed ID: 17709311 [TBL] [Abstract][Full Text] [Related]
19. Expression of thyroid transcription factor-1 in pulmonary and extrapulmonary small cell carcinomas and other neuroendocrine carcinomas of various primary sites. Kaufmann O; Dietel M Histopathology; 2000 May; 36(5):415-20. PubMed ID: 10792482 [TBL] [Abstract][Full Text] [Related]
20. An immunohistochemical comparison of two TTF-1 monoclonal antibodies in atypical squamous lesions and sarcomatoid carcinoma of the lung, and pleural malignant mesothelioma. Klebe S; Swalling A; Jonavicius L; Henderson DW J Clin Pathol; 2016 Feb; 69(2):136-41. PubMed ID: 26281863 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]